Improved survival in matched unrelated donor transplant for childhood ALL since the introduction of high-resolution matching at HLA class i and II

Bone Marrow Transplantation

Volumn 47, Issue 10, 2012, Pages 1294-1300

  Harvey, J ^a   Green, A ^a   Cornish, J ^b   Steward, C ^b   Cummins, M ^b   Keen, L ^a   Culliford, S ^a   Poles, A ^a   Hunt, L ^b   Breslin, P ^b   Li, Y ^a   Moppett, J ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

ALL; HLA matching; Non relapse mortality; OS; Relapse

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER PROGNOSIS; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; FEMALE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONRELAPSE MORTALITY; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE RISK; SCHOOL CHILD; SIBLING; UNRELATED DONORS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 84867399080     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.8     Document Type: Article

References (18)

1. Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004; 104: 1923-1930.
2. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M et al. Highresolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576-4583.
3. Petersdorf EW, Gooley T, Malkki M, Horowitz M. Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. Tissue Antigens 2007; 69(Suppl 1): 25-30.
4. Petersdorf EW. HLA matching in allogeneic stem cell transplantation. Curr Opin Hematol 2004; 11: 386-391.
5. Crocchiolo R, Ciceri F, Fleischhauer K, Oneto R, Bruno B, Pollichieni S et al. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry. Bone Marrow Transplant 2009; 44: 571-577.
6. Macmillan ML, Davies SM, Nelson GO, Chitphakdithai P, Confer DL, King RJ et al. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 2008; 14(Suppl 9): 16-22.
7. Shaw PJ, Kan F, Ahn KW, Spellman SR, Aljurf M, Ayas M et al. Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related or matched unrelated donors. Blood 2010; 116: 4007-4015.
8. Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008; 112: 4318-4327.
9. Klingebiel T, Bader P. HSCT for acute lymphoblastic leukaemia in children. In: Apperley J, Carreras E, Gluckman E, Gratwohl A, Masszi T (eds). The ESH-EBMT Handbook. Haematopoietic Stem Cell Transplantation, 5th Edition forum service editore, Genoa, 2008, pp 506 - 514.
10. Oakhill A, Pamphilon DH, Potter MN, Steward CG, Goodman S, Green A et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 1996; 94: 574-578.
11. Marks DI, Khattry N, Cummins M, Goulden N, Green A, Harvey J et al. Haploidentical stem cell transplantation for children with acute leukaemia. Br J Haematol 2006; 134: 196-201.
12. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis part II: multivariate data analysis - an introduction to concepts and methods. Br J Cancer 2003; 89: 431-436.
13. Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis Part III: multivariate data analysis-choosing a model and assessing its adequacy and fit. Br J Cancer 2003; 89: 605-611.
14. Green A, Clarke E, Hunt L, Canterbury A, Lankester A, Hale G et al. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome. Blood 1999; 94: 2236-2246.
15. Bray RA, Hurley CK, Kamani NR, Woolfrey A, Müller C, Spellman S et al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biol Blood Marrow Transplant 2008; 14(Suppl 9): 45-53.
16. Einsiedel HG, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G et al. Long-term outcome in children with relapsed ALL by riskstratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. J Clin Oncol 2005; 23: 7942-7950.
17. Parker C, Waters R, Leighton C, Hancock J, Sutton R, Moorman AV et al. Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. Lancet 2010; 376: 2009 - 2017.
18. Harvey J, Green A. Survey of human leukocyte antigen matching criteria used in donor selection for haematopoietic stem cell transplantation in the United Kingdom and Ireland (Abstract). Hum Immunol 2009; 70(Suppl 1): 97.